Bluebird Bio Upgraded At Morgan Stanley; Firm Sees 'Innovation At A Discount'
October 05, 2015 at 09:07 AM EDT
bluebird bio Inc (NASDAQ: BLUE) shares are down 42 percent in the last three months and are trading significantly below their ...